Adapalene; Benzoyl Peroxide Patent Expiration
Adapalene; Benzoyl Peroxide is Used for treating acne. It was first introduced by Galderma Laboratories Lp
Adapalene; Benzoyl Peroxide Patents
Given below is the list of patents protecting Adapalene; Benzoyl Peroxide, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Epiduo | US8071644 | Combinations of adapalene and benzoyl peroxide for treating acne lesions | Jul 18, 2027 | Galderma Labs Lp |
Epiduo | US8080537 | Combinations of adapalene and benzoyl peroxide for treating acne lesions | Jul 18, 2027 | Galderma Labs Lp |
Epiduo | US8129362 | Combination/association of adapalene and benzoyl peroxide for treating acne lesions | Jul 18, 2027 | Galderma Labs Lp |
Epiduo | US8445543 | Combinations of adapalene and benzoyl peroxide for treating acne lesions | Jul 12, 2027 | Galderma Labs Lp |
Epiduo | US7820186 | Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt | Nov 23, 2025 | Galderma Labs Lp |
Epiduo | US7964202 | Method for treatment of common acne |
Sep 01, 2024
(Expired) | Galderma Labs Lp |
Epiduo Forte | US8703820 | Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
Mar 12, 2023
(Expired) | Galderma Labs |
Epiduo Forte | US8729127 | Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
Mar 12, 2023
(Expired) | Galderma Labs |
Epiduo Forte | US9381179 | Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
Mar 12, 2023
(Expired) | Galderma Labs |
Epiduo Forte | US9387187 | Administration of 6[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
Mar 12, 2023
(Expired) | Galderma Labs |
Epiduo | US8105618 | Dermatological/cosmetic gels comprising at least one retinoid and/or retinoid salt and benzoyl peroxide |
Dec 23, 2022
(Expired) | Galderma Labs Lp |
Epiduo | US8241649 | Dermatological/cosmetic gels comprising at least one retinoid and/or retinoid salt and benzoyl peroxide |
Dec 23, 2022
(Expired) | Galderma Labs Lp |
Epiduo | US8809305 | Administration of adapalene and benzoyl peroxide for the long-term treatment of acne vulgaris |
Dec 23, 2022
(Expired) | Galderma Labs Lp |
Epiduo | US8936800 | Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt |
Dec 23, 2022
(Expired) | Galderma Labs Lp |
Epiduo Forte | US8445543 | Combinations of adapalene and benzoyl peroxide for treating acne lesions |
Dec 23, 2022
(Expired) | Galderma Labs |
Epiduo Forte | US8785420 | Combination/association of adapalene and benzoyl peroxide for treating acne lesions |
Dec 23, 2022
(Expired) | Galderma Labs |
Epiduo Forte | US8809305 | Administration of adapalene and benzoyl peroxide for the long-term treatment of acne vulgaris |
Dec 23, 2022
(Expired) | Galderma Labs |
Epiduo Forte | US8909305 | Method and system for activating an application on a mobile device |
Dec 23, 2022
(Expired) | Galderma Labs |
Epiduo Forte | US8936800 | Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt |
Dec 23, 2022
(Expired) | Galderma Labs |
Epiduo Forte | US9814690 | Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt |
Dec 23, 2022
(Expired) | Galderma Labs |
Adapalene; Benzoyl Peroxide's Family Patents

Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List